Transcend Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10M Sell
41,047
-2,873
-7% -$669K 0.8% 22
2025
Q4
$9.09M Sell
43,920
-11,458
-21% -$2.27M 0.7% 29
2025
Q3
$10.3M Sell
55,378
-3,486
-6% -$597K 0.72% 29
2025
Q2
$8.99M Sell
58,864
-800
-1% -$123K 0.69% 30
2025
Q1
$9.89M Buy
59,664
+2,422
+4% +$379K 0.71% 28
2024
Q4
$8.28M Sell
57,242
-6,857
-11% -$1.06M 0.6% 37
2024
Q3
$10.4M Sell
64,099
-9,094
-12% -$1.45M 0.7% 29
2024
Q2
$10.7M Sell
73,193
-29,950
-29% -$4.45M 0.78% 23
2024
Q1
$16.3M Sell
103,143
-679
-0.7% -$108K 1.31% 9
2023
Q4
$16.3M Sell
103,822
-8,814
-8% -$1.35M 1.44% 7
2023
Q3
$17.5M Buy
112,636
+60,704
+117% +$10M 1.71% 6
2023
Q2
$8.6M Sell
51,932
-7,701
-13% -$1.24M 0.82% 19
2023
Q1
$9.24M Buy
59,633
+4,429
+8% +$715K 0.96% 16
2022
Q4
$9.75M Buy
55,204
+1,839
+3% +$318K 1.06% 14
2022
Q3
$8.72M Buy
53,365
+194
+0.4% +$32.8K 0.96% 17
2022
Q2
$9.44M Buy
53,171
+2,130
+4% +$380K 0.98% 16
2022
Q1
$9.05M Sell
51,041
-1,094
-2% -$186K 0.81% 20
2021
Q4
$8.92M Buy
52,135
+3,866
+8% +$633K 0.79% 21
2021
Q3
$8M Sell
48,269
-943
-2% -$161K 0.72% 22
2021
Q2
$8.1M Buy
49,212
+8,386
+21% +$1.39M 1.16% 14
2021
Q1
$6.71M Sell
40,826
-616
-1% -$99.7K 0.81% 18
2020
Q4
$6.52M Buy
41,442
+11,830
+40% +$1.75M 0.86% 16
2020
Q3
$4.41M Buy
29,612
+4,514
+18% +$668K 0.8% 25
2020
Q2
$3.53M Sell
25,098
-3,587
-13% -$523K 1.15% 23
2020
Q1
$3.77M Sell
28,685
-932
-3% -$132K 1.13% 16
2019
Q4
$4.32M Buy
+29,617
New +$4.02M 1.16% 15

Other funds holding JNJ

Transcend Capital Advisors's JNJ Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 6.5% in Q1 2026, selling an estimated $669K and leaving 41,047 shares worth $10M. The position accounts for 0.8% of the portfolio, ranked #22.

Transcend Capital Advisors first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $17.5M in Q3 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Transcend Capital Advisors held 41,047 shares of Johnson & Johnson worth $10M as of Q1 2026.
  • Transcend Capital Advisors sold 2,873 Johnson & Johnson shares in Q1 2026, an estimated $669K.
  • Johnson & Johnson made up 0.8% of Transcend Capital Advisors's portfolio in Q1 2026, its #22 holding.
  • Transcend Capital Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Transcend Capital Advisors's Johnson & Johnson position peaked at $17.5M in Q3 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.